Background: In 1941, a Sydney ophthalmologist, Norman McAlister Gregg, correctly identified the link between congenital cataracts in infants and maternal rubella early in pregnancy. Fifty of Gregg's subjects with congenital rubella, born in 1939–1944, were reviewed in 1967 and again in 1991. We reviewed this cohort in 2000–2001, 60 years after their intrauterine infection.
Methods: The subjects underwent full clinical assessment, plus pathology tests, an ophthalmological and cardiological review (including electrocardiography and echocardiography) and HLA histocompatibility testing.
Results: Since they were first seen in 1967, 10 have died (cardiovascular causes , malignant disease , AIDS , and hepatitis C-related cirrhosis ). All surviving men came for review (19) and 13 women (eight women declined). Echocardiography showed mild aortic valve sclerosis in 68%. The prevalence of diabetes (22%), thyroid disorders (19%), early menopause (73%) and osteoporosis (12.5%) was increased compared with the Australian population; 41% had undetectable levels of rubella antibodies. The frequency of HLA-A1 (44%) and HLA-B8 (34%) antigens was increased, and the haplotype HLA-A1, B8, DR3, said to be highly associated with many autoimmune conditions, was present in 25%.
Conclusions: This cohort of people with congenital rubella has illuminated our understanding of viral teratogenesis.
- 1. Gregg NMcA. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 1941; 3: 35-46.
- 2. Weller TH, Neva FA. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc Soc Exp Biol Med 1962; 111: 215-225.
- 3. Parkman PD, Buescher EL, Artenstein MS. Recovery of rubella virus from army recruits. Proc Soc Exp Biol Med 1962; 111: 225-230.
- 4. Swan C, Tostevin AL, Moore B, et al. Congenital defects in infants following infectious diseases during pregnancy. Med J Aust 1943; 2: 201-210.
- 5. Gregg NMcA. Further observations on congenital defects in infants following maternal rubella. Trans Ophthalmol Soc Aust 1944; 4: 119-131.
- 6. Menser MA, Reye RDK. The pathology of congenital rubella: a review written by request. Pathology 1974; 6: 215-622.
- 7. Gregg NMcA, Ramsay Brevis W, Heseltine M, et al. The occurrence of congenital defects in children following maternal rubella during pregnancy. Med J Aust 1945; 2: 122-126.
- 8. Lancaster HO. Deafness as an epidemic disease in Australia. A note on census and institutional data. BMJ 1951; 2: 1429-1432.
- 9. Menser MA, Forrest JM, Slinn RF, et al. Rubella viuria in a 29-year-old woman with congenital rubella. Lancet 1971; 2: 797-798.
- 10. Fuccillo DA, Steele RW, Hensen SA, et al. Impaired cellular immunity to rubella virus in congenital rubella. Infect Immun 1974; 9: 81-84.
- 11. Menser MA, Dods L, Harley JD. A twenty-five year follow-up of congenital rubella. Lancet 1967; 2: 1347-1350.
- 12. Forrest JM, Menser MA, Burgess JA. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971; 2: 332-334.
- 13. McIntosh EDG, Menser MA. A fifty-year follow-up of congenital rubella. Lancet 1992; 340: 414-415.
- 14. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 142-147.
- 15. Akasaka T, Yoshikawa J, Yoshida K, et al. Age-related valvular regurgitation: a study by pulsed Doppler echocardiography. Circulation 1987; 76: 262-265.
- 16. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance. The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834.
- 17. Kenrick KG, Slinn RF, Dorman DC, Menser MA. Immunoglobulins and rubella-virus antibodies in adults with congenital rubella. Lancet 1968; 1: 548-551.
- 18. Honeyman MC, Dorman DC, Menser MA, et al. HL-A antigens in congenital rubella and the role of antigens 1 and 8 in the epidemiology of natural rubella. Tissue Antigens 1975; 5: 12-18.
- 19. Ou D, Mitchell LA, Metzger DL, et al. Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type 1 diabetes mellitus. Diabetologia 2000; 43: 750-762.
- 20. Congenital rubella — 50 years on. Lancet 1991; 337: 668.
- 21. O'Donnell N. History of congenital rubella syndrome. J Vocational Rehabil 1996; 6: 149-157.
- 22. Munro S. A survey of late emerging manifestations of congenital rubella in Canada. Presented at the NUD Conference on late Manifestations of Rubella in Congenitally Deafblind Persons, Dronninglund, Denmark, May 8-12, 1999.
- 23. Reef S, Plotkin S, Cordero JF, et al. Preparing for elimination of congenital rubella syndrome (CRS). Summary of a workshop on CRS elimination in the United States. Clin Infect Dis 2000; 31: 85-95.
- 24. Townsend JJ, Baringer JR, Wolinsky JS, et al. Progressive rubella panencephalitis. Late onset after congenital rubella. N Engl J Med 1975; 292: 990-993.
- 25. Weil ML, Itabashi H, Cremer NE, et al. Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis. N Engl J Med 1975; 292: 994-998.
- 26. Sullivan EV, Burgess MA, Forrest JF. The epidemiology of rubella and congenital rubella in Australia, 1991 to 1997. Commun Dis Intell 1999; 23: 209-214.
- 27. Cutts FT, Robertson SE, Diaz-Ortega J-L, Samuel R. Part 1: The burden of disease from CRS. Control of rubella and congenital rubella syndrome (CRS) in developing countries. Geneva: Department of Vaccines and Biologicals, World Health Organization; 2000: 2-15.
- 28. Gilbert GL. Infections in pregnant women. Med J Aust 2002; 176: 229-236. <eMJA full text>
- 29. Burgess MA. Gregg's rubella legacy 1941-1991. Med J Aust 1992; 156: 138-139.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.